Item 7.01 Regulation FD Disclosure. On March 26, 2026, Rockwell Medical, Inc. made available an updated corporate presentation. A copy of the corporate presentation is furnished herewith as Exhibit 99.1 and incorporated by reference herein. In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
RMTI Rockwell Medical, Inc. - 8-K
Accession
0001628280-26-0211957.019.01
Item 7.01 - Regulation FD Disclosure
129 words
Item 9.01 - Financial Statements and Exhibits
45 words
Item 9.01 Financial Statements and Exhibits. (d) Exhibits The following exhibit is being furnished herewith: EXHIBIT INDEX Exhibit No. Description 99.1 Rockwell Medical, Inc. Corporate Presentation, dated March 26, 2026 104 Cover Page Interactive Data File, formatted in INline XBRL and included as Exhibit 101.